HyperArc Registry Study
Completed
Conditions studied: Brain Metastases, CNS Neoplasm, CNS Disorder, Intracranial
In brief
The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.
Key facts
- Study ID
- NCT05270707
- Run by
- Varian, a Siemens Healthineers Company
- People needed
- 968
- Starts
- 2022-03-31
- Expected to finish
- 2025-03-31
- Last updated by the study team
- 2025-09-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Received or scheduled to receive treatment using the HyperArc treatment method
- Age of legal adult according to local law
- Signed informed consent form, or, informed consent waived by the local ethics board/institutional review board
You may not qualify if…
- None, apart from not meeting Inclusion Criteria
Where it is running
- University of Alabama — Birmingham, Alabama, United States
- Icon Cancer Centre Canberra — Bruce, Australian Capital Territory, Australia
- Icon Cancer Centre Greenslopes — Greenslopes, Queensland, Australia
- Icon Cancer Centre Maroochydore — Maroochydore, Queensland, Australia
- Icon Cancer Centre Gold Coast Private — Southport, Queensland, Australia
- University Hospital Leuven — Leuven, Belgium
- L'IRCCS Ospedale Sacro Cuore - Don Calabria — Negrar, Valpolicella, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.